Arrowpoint Investment Partners »

Verastem shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Verastem (VSTM) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Verastem

Tip: Access up to 7 years of quarterly data

All positions including Verastem held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verastem by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $192k 36k 5.30
2025-09-30 $257k 29k 8.83

More positions owned by Arrowpoint Investment Partners

Ishares Tr Expanded Tech Call Option (IGV)
Kraneshares Trust Csi Chi Internet (KWEB)
Alphabet Cap Stk Cl A (GOOGL)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Ishares Msci Brazil Etf Call Option (EWZ)
Ase Technology Hldg Sponsored Ads (ASX)
Ionis Pharmaceuticals (IONS)
Neurocrine Biosciences (NBIX)
Axsome Therapeutics (AXSM)
BioMarin Pharmaceutical (BMRN)
Ascendis Pharma A/s Sponsored Adr (ASND)
Ptc Therapeutics I (PTCT)
Pfizer (PFE)
Regeneron Pharmaceuticals (REGN)
Johnson & Johnson (JNJ)

View all positions for Arrowpoint Investment Partners

Top funds holding Verastem

Rtw Investments
BlackRock
Deep Track Capital
Armistice Capital
Vanguard Group
Nantahala Capital Management
State Street Corporation
Vanguard Capital Management
Stonepine Capital Management
Foresite Capital Management VI
Millennium Management
Citadel Advisors
Morgan Stanley
Rosalind Advisors
Alyeska Investment Group

View all funds holding Verastem